Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter –defibrillator to confirm appropriate ventricular fibrillation detection

The subcutaneous implantable cardioverter –defibrillator (S-ICD) remains a new technology requiring accurate assessment of the various aspects of its functioning. Isolated cases of delayed sensing of ventricular arrhythmia have been described.

Source: Heart Rhythm - April 27, 2018 Category: Cardiology Authors: Jean-Benoit le Polain de Waroux, Sylvain Ploux, Pierre Mondoly, Romain Eschalier, Marc Strik, Laura Houard, Bertrand Pierre, Samuel Buliard, Nicolas Klotz, Philippe Ritter, Michel Haissaguerre, Karim Mahfouz, Pierre Bordachar Tags: Featured Article Source Type: research